Guest guest Posted December 22, 2010 Report Posted December 22, 2010 http://www.dldjournalonline.com/article/PIIS1590865810003282/abstract?rss=yes Management of chronic hepatitis C in childhood: The impact of therapy in the clinical practice during the first 2 decades Flavia Bortolottia, Giuseppe Indolfib, Lucia Zancanc, Raffaella Giacchinod, la Verucchie, Calogero Cammàf, Cristiana Barberag, Massimo Restib, Grazia Marazzid, Guidoh Received 18 July 2010; accepted 14 October 2010. published online 26 November 2010. Corrected Proof Abstract Background and aim Treatment of chronic hepatitis C in children is controversial and its role in the clinical practice is unknown. We retrospectively investigated the impact of treatment in a large cohort of children with chronic hepatitis C over the past 20 years. Methods 376 hepatitis C virus RNA positive children were recruited consecutively in five Italian centres since 1990 and followed for 1–17 years. Results 86 (23%) subjects were treated: 73 with recombinant interferon alone and 13 with pegylated-interferon and ribavirin. Sustained clearance of hepatitis C virus RNA was observed in 25% of the former, in 92% of the latter and in 9% of untreated cases (p<0.001). Loss of viraemia was recorded in all children with genotype 2–3 and in 6 of 7 with hepatitis C virus genotype 1 treated with combination therapy. At last evaluation 45% of patients were young adults and 15% had cleared viraemia. Overall, 152 (40%) were putative candidates to therapy. Conclusions Few Italian children with chronic hepatitis C have been treated in the past 20 years. The poor propensity to spontaneous clearance of viraemia and the efficacy of combination therapy should encourage to consider treatment in attempt to shorten the duration of viral replication. Keywords: Children, Hepatitis C virus, Natural history, Sustained virological response, Treatment a University of Padua, Padua, Italy b Paediatric and Liver Unit, Meyer Children's University-Hospital of Florence, Florence, Italy c Department of Paediatrics, University of Padua, Padua, Italy d Department of Infectious Diseases, Gaslini Institute, Genoa, Italy e Clinic of Infectious Diseases, Policlinico S. Orsola, Bologna, Italy f Cattedra di Gastroenterologia, University of Palermo, Palermo, Italy g Paediatric Clinic, University of Turin, Turin, Italy h Department of Pathology, University of Padua, Padua, Italy Corresponding author at: Liver and Paediatric Unit, Meyer Children's University Hospital of Florence, Department of Sciences for Women and Child's Health, University of Florence, Viale Pieraccini 24, I-50139 Florence, Italy. Tel.: +39 055 5662542; fax: +39 055 570380. PII: S1590-8658(10)00328-2 doi:10.1016/j.dld.2010.10.008 © 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Inc All rights reserved. Quote
Guest guest Posted December 22, 2010 Report Posted December 22, 2010 http://www.dldjournalonline.com/article/PIIS1590865810003282/abstract?rss=yes Management of chronic hepatitis C in childhood: The impact of therapy in the clinical practice during the first 2 decades Flavia Bortolottia, Giuseppe Indolfib, Lucia Zancanc, Raffaella Giacchinod, la Verucchie, Calogero Cammàf, Cristiana Barberag, Massimo Restib, Grazia Marazzid, Guidoh Received 18 July 2010; accepted 14 October 2010. published online 26 November 2010. Corrected Proof Abstract Background and aim Treatment of chronic hepatitis C in children is controversial and its role in the clinical practice is unknown. We retrospectively investigated the impact of treatment in a large cohort of children with chronic hepatitis C over the past 20 years. Methods 376 hepatitis C virus RNA positive children were recruited consecutively in five Italian centres since 1990 and followed for 1–17 years. Results 86 (23%) subjects were treated: 73 with recombinant interferon alone and 13 with pegylated-interferon and ribavirin. Sustained clearance of hepatitis C virus RNA was observed in 25% of the former, in 92% of the latter and in 9% of untreated cases (p<0.001). Loss of viraemia was recorded in all children with genotype 2–3 and in 6 of 7 with hepatitis C virus genotype 1 treated with combination therapy. At last evaluation 45% of patients were young adults and 15% had cleared viraemia. Overall, 152 (40%) were putative candidates to therapy. Conclusions Few Italian children with chronic hepatitis C have been treated in the past 20 years. The poor propensity to spontaneous clearance of viraemia and the efficacy of combination therapy should encourage to consider treatment in attempt to shorten the duration of viral replication. Keywords: Children, Hepatitis C virus, Natural history, Sustained virological response, Treatment a University of Padua, Padua, Italy b Paediatric and Liver Unit, Meyer Children's University-Hospital of Florence, Florence, Italy c Department of Paediatrics, University of Padua, Padua, Italy d Department of Infectious Diseases, Gaslini Institute, Genoa, Italy e Clinic of Infectious Diseases, Policlinico S. Orsola, Bologna, Italy f Cattedra di Gastroenterologia, University of Palermo, Palermo, Italy g Paediatric Clinic, University of Turin, Turin, Italy h Department of Pathology, University of Padua, Padua, Italy Corresponding author at: Liver and Paediatric Unit, Meyer Children's University Hospital of Florence, Department of Sciences for Women and Child's Health, University of Florence, Viale Pieraccini 24, I-50139 Florence, Italy. Tel.: +39 055 5662542; fax: +39 055 570380. PII: S1590-8658(10)00328-2 doi:10.1016/j.dld.2010.10.008 © 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Inc All rights reserved. Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.